{
  "data": {
    "indicator": {
      "slug": "cumulative-drugs-added-via-negotiation-in-reimbursement-drug-list",
      "name": "Cumulative drugs added via negotiation in reimbursement drug list",
      "definition": "Cumulative number of drugs added to a reimbursement drug formulary through price negotiations.",
      "unit": "count",
      "scale": "1",
      "default_unit": "count",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "count",
    "region": {
      "code": "CN",
      "name": "China",
      "type": "country"
    },
    "points": [
      {
        "period_start": "2018-05-31",
        "period_label": "as of 28 Nov 2024",
        "value": 530,
        "scale": "1",
        "unit": "count",
        "value_type": "actual",
        "statistic_id": "stat_20KAVP0JDSCT0QSHHFHFN0978Z",
        "url": "https://statorigin.org/stat/stat_20KAVP0JDSCT0QSHHFHFN0978Z",
        "source_org": "NHSA",
        "source": {
          "org": "National Healthcare Security Administration",
          "org_short_name": "NHSA",
          "document_title": "国家医疗保障局 医保动态 国家医保局 人力资源社会保障部印发2024年版国家医保药品目录",
          "document_url": "https://www.nhsa.gov.cn/art/2024/11/28/art_14_14884.html",
          "locator": "国家医保局 人力资源社会保障部印发2024年版国家医保药品目录",
          "published_date": "2024-11-28"
        }
      }
    ],
    "available_regions": [
      "CN"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}